Established in 2007, the company is a one-stop integrated service provider for small molecule innovative drug development and commercial production. It is committed to drug discovery, pharmaceutical process research and development, and commercial production of APIs and intermediates. The main business mainly covers drug discovery (CRO), process research and development (CRO/CDMO), and commercial production (including CMO). Main products and businesses: Drug discovery includes medicinal chemistry research, synthetic chemistry research, and pharmacokinetics research; process research and development includes process chemistry and process development and CMC research for APIs; commercial production includes customized production of new drugs (CMO) and R&D, production and sales of independent generic pharmaceutical products.
No Data